111 related articles for article (PubMed ID: 34593439)
1. Intracellular IL-33 Attenuates Extracellular IL-33-induced Cholangiocarcinoma Cell Proliferation and Invasion
Yangngam S; Thongchot S; Vaeteewoottacharn K; Thuwajit P; Hermoso MA; Okada S; Thuwajit C
Anticancer Res; 2021 Oct; 41(10):4917-4928. PubMed ID: 34593439
[TBL] [Abstract][Full Text] [Related]
2. CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-κB pathway promotes cholangiocarcinoma migration and invasion.
Dana P; Saisomboon S; Kariya R; Okada S; Obchoei S; Sawanyawisuth K; Wongkham C; Pairojkul C; Wongkham S; Vaeteewoottacharn K
Cell Oncol (Dordr); 2020 Apr; 43(2):211-222. PubMed ID: 31729681
[TBL] [Abstract][Full Text] [Related]
3. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway.
Zhao W; Yang S; Chen J; Zhao J; Dong J
Life Sci; 2018 Oct; 210():224-234. PubMed ID: 30193944
[TBL] [Abstract][Full Text] [Related]
4. Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK-NF-κB signaling pathway.
Lee GR; Jang SH; Kim CJ; Kim AR; Yoon DJ; Park NH; Han IS
Clin Exp Metastasis; 2014 Dec; 31(8):897-907. PubMed ID: 25217963
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines.
Dokduang H; Jamnongkarn W; Promraksa B; Suksawat M; Padthaisong S; Thanee M; Phetcharaburanin J; Namwat N; Sangkhamanon S; Titapun A; Khuntikeo N; Klanrit P; Loilome W
Drug Des Devel Ther; 2020; 14():2319-2334. PubMed ID: 32606601
[TBL] [Abstract][Full Text] [Related]
6. Homophilic Interaction of CD147 Promotes IL-6-Mediated Cholangiocarcinoma Invasion via the NF-κB-Dependent Pathway.
Dana P; Kariya R; Lert-Itthiporn W; Seubwai W; Saisomboon S; Wongkham C; Okada S; Wongkham S; Vaeteewoottacharn K
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948304
[TBL] [Abstract][Full Text] [Related]
7. Comparative Proteomic Analysis of Human Cholangiocarcinoma Cell Lines: S100A2 as a Potential Candidate Protein Inducer of Invasion.
Wasuworawong K; Roytrakul S; Paemanee A; Jindapornprasert K; Komyod W
Dis Markers; 2015; 2015():629367. PubMed ID: 25999659
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration.
Janpipatkul K; Suksen K; Borwornpinyo S; Jearawiriyapaisarn N; Hongeng S; Piyachaturawat P; Chairoungdua A
Cell Signal; 2014 Aug; 26(8):1668-79. PubMed ID: 24726839
[TBL] [Abstract][Full Text] [Related]
9. S100A8 facilitates cholangiocarcinoma metastasis via upregulation of VEGF through TLR4/NF‑κB pathway activation.
Pan S; Hu Y; Hu M; Xu Y; Chen M; Du C; Cui J; Zheng P; Lai J; Zhang Y; Bai J; Jiang P; Zhu J; He Y; Wang J
Int J Oncol; 2020 Jan; 56(1):101-112. PubMed ID: 31746424
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis.
Zhou QX; Jiang XM; Wang ZD; Li CL; Cui YF
Med Oncol; 2015 Apr; 32(4):105. PubMed ID: 25744243
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: implications for targeted therapy.
Seubwai W; Wongkham C; Puapairoj A; Khuntikeo N; Pugkhem A; Hahnvajanawong C; Chaiyagool J; Umezawa K; Okada S; Wongkham S
PLoS One; 2014; 9(8):e106056. PubMed ID: 25170898
[TBL] [Abstract][Full Text] [Related]
12. NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells.
Saengboonmee C; Phoomak C; Supabphol S; Covington KR; Hampton O; Wongkham C; Gibbs RA; Umezawa K; Seubwai W; Gingras MC; Wongkham S
Life Sci; 2020 Dec; 262():118548. PubMed ID: 33038372
[TBL] [Abstract][Full Text] [Related]
13. Diethyldithiocarbamate suppresses an NF-kappaB dependent metastatic pathway in cholangiocarcinoma cells.
Srikoon P; Kariya R; Kudo E; Goto H; Vaeteewoottacharn K; Taura M; Wongkham S; Okada S
Asian Pac J Cancer Prev; 2013; 14(7):4441-6. PubMed ID: 23992017
[TBL] [Abstract][Full Text] [Related]
14. Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma.
Poosekeaw P; Pairojkul C; Sripa B; Sa Ngiamwibool P; Iamsaard S; Sakonsinsiri C; Thanan R; Ungarreevittaya P
PLoS One; 2021; 16(11):e0259075. PubMed ID: 34780466
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Tumor Growth against Chemoresistant Cholangiocarcinoma by a Proapoptotic Peptide Targeting Interleukin-4 Receptor.
Permpoon U; Khan F; Vadevoo SMP; Gurung S; Gunassekaran GR; Kim MJ; Kim SH; Thuwajit P; Lee B
Mol Pharm; 2020 Nov; 17(11):4077-4088. PubMed ID: 32881535
[TBL] [Abstract][Full Text] [Related]
16. Mycoepoxydiene induces apoptosis and inhibits TPA-induced invasion in human cholangiocarcinoma cells via blocking NF-κB pathway.
Li W; Li M; Su X; Qin L; Miao M; Yu C; Shen Y; Luo Q; Chen Q
Biochimie; 2014 Jun; 101():183-91. PubMed ID: 24486723
[TBL] [Abstract][Full Text] [Related]
17. The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma.
Di Matteo S; Nevi L; Costantini D; Overi D; Carpino G; Safarikia S; Giulitti F; Napoletano C; Manzi E; De Rose AM; Melandro F; Bragazzi M; Berloco PB; Giuliante F; Grazi G; Giorgi A; Cardinale V; Adorini L; Gaudio E; Alvaro D
PLoS One; 2019; 14(1):e0210077. PubMed ID: 30677052
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic activity of retinoic acid receptor γ is exhibited through activation of the Akt/NF-κB and Wnt/β-catenin pathways in cholangiocarcinoma.
Huang GL; Luo Q; Rui G; Zhang W; Zhang QY; Chen QX; Shen DY
Mol Cell Biol; 2013 Sep; 33(17):3416-25. PubMed ID: 23798555
[TBL] [Abstract][Full Text] [Related]
19. The Upregulation of OCT4 in Acidic Extracellular pH is Associated with Gemcitabine Resistance in Cholangiocarcinoma Cell Lines.
Choodetwattana P; Proungvitaya S; Jearanaikoon P; Limpaiboon T
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2745-2748. PubMed ID: 31554372
[TBL] [Abstract][Full Text] [Related]
20. Cratoxylum formosum Extracts Inhibit Growth and Metastasis of Cholangiocarcinoma Cells by Modulating the NF-κB and STAT3 Pathways.
Senggunprai L; Thammaniwit W; Kukongviriyapan V; Prawan A; Kaewseejan N; Siriamornpun S
Nutr Cancer; 2016; 68(2):328-41. PubMed ID: 26908056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]